| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000254109.1 |
Gefitinib |
Sarcoma |
0.033838777 |
Resistant |
| ENSG00000254109.1 |
Gefitinib |
Breast invasive carcinoma |
0.011054047 |
Sensitive |
| ENSG00000254109.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.022230631 |
Sensitive |
| ENSG00000254109.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.019161183 |
Sensitive |
